Closed vs modular automation defines how high-throughput screening laboratories balance efficiency and flexibility. Closed ...

Charles River Laboratories today announced an enhanced In Vitro Fertility (IVF) service bundle designed to accelerate rat-model programs across therapeutics areas, including oncology, neurology, ...

The global hydrogel market is growing steadily, expected to be valued at around US$ 37.6 billion in 2026 and projected to ...

The U.S. Food and Drug Administration (FDA) is moving to speed drug development and review by launching real-time clinical trials. The move could soon mean more ...

BioticsAI CEO Robhy Bustami joined Isabelle Johannessen on Build Mode to discuss how the company has navigated a highly ...

For pharmaceutical and life sciences companies ready to embrace this moment, the 10 principles aren't a burden. They're a ...

When a patient in an early-phase drug trial experiences a serious side effect today, weeks or even months can pass before ...

The U.S. Food and Drug Administration is planning to launch a pilot program aimed at advancing real-time clinical trials ...

FDB (First Databank, Inc.), the leading provider of drug knowledge that helps healthcare professionals make precise ...

The FDA has begun testing real-time tracking of safety and efficacy data from early-phase clinical trials, aiming to speed detection of adverse events and potential benefits. Two ongoing studies by ...

Optimal microbial sampling approaches for pharmaceutical environments include surface, passive air, and active air monitoring ...

Resolving the mechanism of RXR ligand-dependent NR4A-RXR nuclear receptor heterodimer activation requires a diverse ligand set that includes heterodimer-selective agonists.